UNSPECIFIED INGREDIENT for Hypercholesterolaemia: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 15 adverse event reports in the FDA FAERS database where UNSPECIFIED INGREDIENT was used for Hypercholesterolaemia.
Most Reported Side Effects for UNSPECIFIED INGREDIENT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,090 | 8.0% | 2,089 | 308 |
| Off label use | 1,306 | 5.0% | 324 | 483 |
| Drug ineffective | 1,227 | 4.7% | 154 | 338 |
| Completed suicide | 1,190 | 4.6% | 1,189 | 170 |
| Nausea | 1,041 | 4.0% | 234 | 514 |
| Fatigue | 1,020 | 3.9% | 167 | 402 |
| Dyspnoea | 934 | 3.6% | 270 | 594 |
| Pneumonia | 903 | 3.5% | 310 | 719 |
| Asthenia | 894 | 3.4% | 237 | 506 |
| Vomiting | 877 | 3.4% | 244 | 528 |
| Diarrhoea | 821 | 3.1% | 152 | 457 |
| Pain | 701 | 2.7% | 128 | 299 |
| Dizziness | 692 | 2.6% | 88 | 283 |
| Headache | 681 | 2.6% | 125 | 261 |
| Pyrexia | 658 | 2.5% | 140 | 499 |
Other Indications for UNSPECIFIED INGREDIENT
Product used for unknown indication (6,768)
Rheumatoid arthritis (394)
Non-small cell lung cancer (276)
Cardiac failure (261)
Type 2 diabetes mellitus (229)
Diffuse large b-cell lymphoma (210)
Covid-19 (207)
Malignant melanoma (186)
Hiv infection (185)
Suspected suicide (172)
Other Drugs Used for Hypercholesterolaemia
EVOLOCUMAB (23,505)
ATORVASTATIN (5,615)
ALIROCUMAB (4,924)
SIMVASTATIN (3,010)
ROSUVASTATIN (2,690)
EZETIMIBE (1,589)
PRAVASTATIN (764)
INCLISIRAN (486)
FENOFIBRATE (286)
FLUVASTATIN (264)